These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
965 related articles for article (PubMed ID: 17173937)
1. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions. de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937 [TBL] [Abstract][Full Text] [Related]
2. UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders. de Lago E; Fernández-Ruiz J; Ortega-Gutiérrez S; Cabranes A; Pryce G; Baker D; López-Rodríguez M; Ramos JA Eur Neuropsychopharmacol; 2006 Jan; 16(1):7-18. PubMed ID: 16006105 [TBL] [Abstract][Full Text] [Related]
3. A potent and selective inhibitor of endocannabinoid uptake, UCM707, potentiates antinociception induced by cholestasis. Hasanein P; Javanmardi K Fundam Clin Pharmacol; 2008 Oct; 22(5):517-22. PubMed ID: 18844724 [TBL] [Abstract][Full Text] [Related]
4. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease. Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443 [TBL] [Abstract][Full Text] [Related]
5. Influence of supidimide on brain neurotransmitter systems of rats and mice. Hennies HH; Günzler WA; Flohé L Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511 [TBL] [Abstract][Full Text] [Related]
6. Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels. de Lago E; Petrosino S; Valenti M; Morera E; Ortega-Gutierrez S; Fernandez-Ruiz J; Di Marzo V Biochem Pharmacol; 2005 Aug; 70(3):446-52. PubMed ID: 15963472 [TBL] [Abstract][Full Text] [Related]
7. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. Ricaurte GA; Martello AL; Katz JL; Martello MB J Pharmacol Exp Ther; 1992 May; 261(2):616-22. PubMed ID: 1374470 [TBL] [Abstract][Full Text] [Related]
8. Anxiolytic property of estrogen related to the changes of the monoamine levels in various brain regions of ovariectomized rats. Pandaranandaka J; Poonyachoti S; Kalandakanond-Thongsong S Physiol Behav; 2006 Apr; 87(4):828-35. PubMed ID: 16545402 [TBL] [Abstract][Full Text] [Related]
9. Cocaine accumulates in dopamine-rich regions of primate brain after i.v. administration: comparison with mazindol distribution. Madras BK; Kaufman MJ Synapse; 1994 Nov; 18(3):261-75. PubMed ID: 7855738 [TBL] [Abstract][Full Text] [Related]
10. Effects of unilateral labyrinthectomy on the norepinephrine content in forebrain and cerebellar structures of albino rats. D'Ascanio P; Arrighi P; Fascetti F; Pompeiano O Arch Ital Biol; 2000 Jul; 138(3):241-70. PubMed ID: 10951897 [TBL] [Abstract][Full Text] [Related]
11. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain. Gagnaire F; Chalansonnet M; Carabin N; Micillino JC Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643 [TBL] [Abstract][Full Text] [Related]
12. The effects of acetaldehyde on nicotine-induced transmitter levels in young and adult brain areas. Sershen H; Shearman E; Fallon S; Chakraborty G; Smiley J; Lajtha A Brain Res Bull; 2009 Aug; 79(6):458-62. PubMed ID: 19389462 [TBL] [Abstract][Full Text] [Related]
13. Region-specific alterations in dopamine and serotonin metabolism in brains of rats exposed to low levels of lead. Kala SV; Jadhav AL Neurotoxicology; 1995; 16(2):297-308. PubMed ID: 7566689 [TBL] [Abstract][Full Text] [Related]
14. Effect of acute administration of hypericum perforatum-CO2 extract on dopamine and serotonin release in the rat central nervous system. Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E Pharmacopsychiatry; 2000 Jan; 33(1):14-8. PubMed ID: 10721879 [TBL] [Abstract][Full Text] [Related]
15. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain. Rastogi RB; Singhal RL J Pharmacol Exp Ther; 1976 Sep; 198(3):609-18. PubMed ID: 978462 [TBL] [Abstract][Full Text] [Related]
16. UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide. de Lago E; Fernández-Ruiz J; Ortega-Gutiérrez S; Viso A; López-Rodríguez ML; Ramos JA Eur J Pharmacol; 2002 Aug; 449(1-2):99-103. PubMed ID: 12163112 [TBL] [Abstract][Full Text] [Related]
17. Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum. Calapai G; Crupi A; Firenzuoli F; Inferrera G; Squadrito F; Parisi A; De Sarro G; Caputi A Pharmacopsychiatry; 2001 Mar; 34(2):45-9. PubMed ID: 11302563 [TBL] [Abstract][Full Text] [Related]
18. Immediate and "day-after" effects of morphine on dopamine and serotonin metabolism in various structures of the rat brain. Antkiewicz-Michaluk L; Romańska I; Vetulani J Pol J Pharmacol; 1995; 47(4):355-8. PubMed ID: 8616517 [TBL] [Abstract][Full Text] [Related]
19. Effect of NOS inhibitor on forced swim test and neurotransmitters turnover in the mouse brain. Karolewicz B; Paul IA; Antkiewicz-Michaluk L Pol J Pharmacol; 2001; 53(6):587-96. PubMed ID: 11985332 [TBL] [Abstract][Full Text] [Related]
20. Neurochemical studies on central dopamine neurons--regional characterization of dopamine turnover. Hallman H; Jonsson G Med Biol; 1984; 62(3):198-209. PubMed ID: 6492900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]